Dr Samuel Osei

Biotech & MedTech Analyst

Clinical-stage biotech, medical devices, and digital health with an ASX and NASDAQ dual-market lens.

Voice: clinical. Phase II/III readout framing TGA and FDA parallel pathways Addressable patient population sizing